# Study Evaluating Single Doses Of SBI-087 In Japanese Subjects With Rheumatoid Arthritis

> **NCT00815906** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 20 (actual)

## Conditions studied

- Arthritis, Rheumatoid

## Interventions

- **DRUG:** SBI-087
- **DRUG:** SBI-087
- **DRUG:** SBI-087
- **DRUG:** SBI-087

## Key facts

- **NCT ID:** NCT00815906
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2012-04
- **Final completion:** 2012-05
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2024-08-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00815906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00815906, "Study Evaluating Single Doses Of SBI-087 In Japanese Subjects With Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00815906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*